Skip to main content

Rhode Island Republican House Leader Embraces Marijuana Legalization

Outgoing Rep. Dana Rohrabacher (R-CA) reflected on his 30 years of service in Congress in a wide-ranging farewell speech on Wednesday, and he dedicated several minutes to talking about progress he helped achieve on marijuana reform.

“I cannot think of a life I would rather have lived—the highs and the lows, the idealism and the pragmatism, the courage and the weakness, the disappointments, and yes, the joyous outcomes that I have seen here as part of this living institution in its 230 years of legislative service to the people of the United States,” he said.

Rohrabacher, who lost his seat to Democrat Harley Rouda in this month’s midterm election, ran down a list of achievements he was proud of and also defended himself against claims that he was Russian President Vladimir Putin’s “favorite congressman.” About half-way through the speech, which he titled, “Standing Against The Tide,” he turned his attention to cannabis.

The “conservative credentials” that he earned during his time as President Ronald Reagan’s special assistant enabled him to “talk to conservative people throughout the country—and, yes, throughout the House and the Senate—on the issue of cannabis,” Rohrabacher said.

“The fact is, marijuana created an illusion of disruption and of decadence in the American peoples’s minds, because in the late sixties the use of marijuana was so public and it was identified as something with hippies and people who didn’t like American culture. Well, the fact is, cannabis has tremendous service to give to the people of our country who are suffering from various maladies.”

Elderly people suffering from pain or lack of appetite, children with epilepsy and even individuals working to kick opioid addictions can benefit from marijuana, he said on the House floor. Cannabis “is not a gateway door into the use of opiates,” but rather “a way out.”

Finally, Rohrabacher described one of his most well-known legislative accomplishments: sponsoring an amendment that prohibits the Justice Department from using federal funds to interfere in state-legal medical cannabis programs. That amendment, he said, helped a burgeoning legal market balloon into a $6 billion industry.

“That is $6 billion not going to the drug cartels in Mexico. That is $6 billion of which can be spent helping people, rather than trying to put someone in jail for consuming a weed, using all the money for law enforcement, jails, judges’s time and police time, rather than trying to protect the American people. What a waste.

“My colleagues joined me in that. I think that has been a wonderful accomplishment that I am very, very proud of and very grateful that I had the opportunity to be here and express that in debate and to reach out to my fellow congressmen here from both sides of the aisle and mobilize a majority that got that passed so that the federal government cannot supersede state law now when it comes to medical marijuana.”

The congressman closed the 30-minute speech by emphasizing his gratitude for having had the opportunity to serve. As one of the most vocal marijuana reform advocates on the GOP side of the House, Rohrabacher’s absence could potentially complicate bipartisan legislative efforts.

But at the same time, with a new Democratic majority and multiple incoming committee chairs already talking about reform, the chamber could be well-positioned to continue the work that Rohrabacher played a key role in advancing, even in his absence.

GOP Congressman Visits Marijuana Dispensary With Bus Full Of Senior Citizens

Photo courtesy of C-SPAN.

Original Article Source: https://www.marijuanamoment.net/rhode-island-republican-house-leader-embraces-marijuana-legalization/

Comments

Post a Comment

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...
Post a Comment
Read more